SELECT B — Selectimmune Pharma AB Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- SEK41.38m
- SEK35.54m
Annual balance sheet for Selectimmune Pharma AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.049 | 34.9 | 23 | 26.6 | 11.2 |
| Net Total Receivables | 0 | 1.4 | 0.104 | 0.63 | 0.6 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.049 | 38.3 | 23.2 | 27.4 | 11.9 |
| Net Property, Plant And Equipment | — | — | 1.92 | 1.52 | 1.12 |
| Total Assets | 0.049 | 38.3 | 25.1 | 28.9 | 13 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.012 | 5.65 | 0.712 | 3.02 | 1.22 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.012 | 5.65 | 0.712 | 3.02 | 1.22 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 0.037 | 32.6 | 24.4 | 25.9 | 11.8 |
| Total Liabilities & Shareholders' Equity | 0.049 | 38.3 | 25.1 | 28.9 | 13 |
| Total Common Shares Outstanding |